Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04456816
Recruitment Status : Recruiting
First Posted : July 7, 2020
Last Update Posted : September 22, 2021
Information provided by (Responsible Party):
SynAct Pharma Aps

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 1, 2022
Estimated Study Completion Date : December 31, 2022